CurrentHighmark Blue Cross Blue Shield WnyPolicy G-23002

Genetic Testing: Once per Lifetime

Customize your policy alerts

Sign up for Highmark Blue Cross Blue Shield Wny Policy G-23002 alerts

Get alerted when Policy G-23002 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Governs reimbursement for specific germline genetic sequencing procedures for Highmark BCBS WNY Essential Plan members, allowing coverage once per member lifetime unless overridden by provider, state, or federal requirements.

Policy Summary

PayerHighmark Blue Cross Blue Shield Wny

PolicyGenetic Testing: Once per Lifetime

Policy CodePolicy G-23002

Change TypeCoding update (related codes added)

Effective DateJul 1, 2026

Last ReviewOct 23, 2025

Next Review Date

Key ActionObtain required authorization and confirm medical necessity; improper coding may result in claim rejection, denial, recoupment, or adjustment.

SourceLink

POLICY UPDATE CHANGES

Updated Related Coding section by adding new codes.

once/lifetimeallowed sequencing frequency

EP onlyprogram scope

excludedreinterpretation reimbursed

07/01/2026policy effective

Coverage Criteria

Lifetime sequencing limit

Reimbursement is allowed for specified germline genetic sequencing procedures with a lifetime limitation.

The health plan allows reimbursement for the genetic procedures listed in the Related Coding section one time per member lifetime unless provider, state, or federal contracts and/or requirements indicate otherwise.

Repeat sequencing is not required for future interpretation or re-analysis; reinterpretation of the original results is not separately reimbursable.

Applies specifically to the procedures enumerated under 'Genetic Sequencing: Once per Lifetime Procedures' in Related Coding.

Billing and authorization requirements

General claim and billing conditions that affect coverage and reimbursement.

Services must meet authorization and medical necessity guidelines appropriate to the procedure, diagnosis, and the member's state of residence.

Services should be billed with appropriate CPT, HCPCS, and/or revenue codes; billed codes must be fully supported in the medical record and/or office notes.

If appropriate coding/billing guidelines or current reimbursement policies are not followed, the plan may: reject or deny the claim; recover and/or recoup claim payment; or adjust the reimbursement to reflect the appropriate services and/or procedures performed.

These reimbursement policies may be superseded by provider, state, federal, or CMS mandates; the plan reserves the right to recoup or recover claims payment to the effective date if policy implementation is delayed.

Related Coding

Genetic Sequencing: Once per Lifetime ProceduresCPT | HCPCSCovered

No codes listed

Sequencing frequency limit

Sequencing frequency limitOne sequencing reimbursement per member lifetime for the genetic procedures listed in Related Coding; repeat sequencing for reinterpretation is not separately reimbursable.

ScopeApplies to specified germline genetic sequencing procedures unless provider, state, or federal requirements indicate otherwise.

RationaleThe germline genotype does not change during a member's lifetime; reinterpretation of results does not require repeat sequencing.

Provider Actions & Billing Requirements

Note

Authorization, coding, and billing requirements

Services must meet authorization and medical necessity guidelines appropriate to the procedure and diagnosis and to the member's state of residence; use proper billing and submission guidelines and industry-standard codes on all claim submissions. Improper coding or failure to follow coding/billing guidelines may result in claim rejection or denial, recovery/recoupment of payment, or adjustment of reimbursement.

Bill services with appropriate CPT, HCPCS, and/or revenue codes and ensure claims are fully supported in the medical record and/or office notes.
Be aware that provider, state, federal, or CMS mandates may supersede this policy.

Definitions

Germline

DefinitionCells arising from the germ cells containing genetic code that may be passed down to future generations. May also be referred to as hereditary or constitutional.

Relevance to policyPolicy limits reimbursement for germline genetic sequencing to one per member lifetime because the germline genotype does not change over a lifetime.

Alternate termsHereditary; constitutional.

Genotype

DefinitionThe genotype is the individual organism's unique set of all the genes.

Policy noteGenotype is considered stable over a member's lifetime; repeat sequencing is not required solely to reassess genotype.

Use in clinical contextInforms interpretation of variants and clinical decision-making when combined with patient history.

Sequencing

DefinitionDetermining the identity of each nucleotide (one of the four chemical bases) to identify the genetic information carried in a DNA segment.

Policy implicationSequencing procedures listed in Related Coding are limited to one reimbursement per member lifetime.

PurposeUsed to generate the genetic data that may later be reinterpreted without requiring a new sequencing procedure.

Variant

DefinitionNucleotide deviation from a reference DNA sequence; clinically classified (Pathogenic; Likely pathogenic; Variant of uncertain (or unknown) significance (VUS); Likely benign; Benign).

Classification dynamicsAs evidence evolves, prior variant classifications may require modification; each laboratory assigns risk assessment per accepted schemes.

Reimbursement impactReinterpretation of previously obtained sequencing results (reclassification of variants) is not separately reimbursable; repeat sequencing is not required for reinterpretation.

Policy Summary

PayerHighmark Blue Cross Blue Shield Wny

PolicyGenetic Testing: Once per Lifetime

Policy CodePolicy G-23002

Change TypeCoding update (related codes added)

Effective DateJul 1, 2026

Last ReviewOct 23, 2025

Next Review Date

Key ActionObtain required authorization and confirm medical necessity; improper coding may result in claim rejection, denial, recoupment, or adjustment.

SourceLink

On This Page

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

Genetic Testing: Once per Lifetime

Customize your policy alerts

Sign up for Highmark Blue Cross Blue Shield Wny Policy G-23002 alerts

Get alerted when Policy G-23002 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Coverage Criteria

Lifetime sequencing limit

Reimbursement is allowed for specified germline genetic sequencing procedures with a lifetime limitation.

Repeat sequencing is not required for future interpretation or re-analysis; reinterpretation of the original results is not separately reimbursable.

Applies specifically to the procedures enumerated under 'Genetic Sequencing: Once per Lifetime Procedures' in Related Coding.

Billing and authorization requirements

General claim and billing conditions that affect coverage and reimbursement.

Services must meet authorization and medical necessity guidelines appropriate to the procedure, diagnosis, and the member's state of residence.

Services should be billed with appropriate CPT, HCPCS, and/or revenue codes; billed codes must be fully supported in the medical record and/or office notes.

Related Coding

Genetic Sequencing: Once per Lifetime ProceduresCPT | HCPCSCovered

No codes listed

Sequencing frequency limit

Sequencing frequency limitOne sequencing reimbursement per member lifetime for the genetic procedures listed in Related Coding; repeat sequencing for reinterpretation is not separately reimbursable.

ScopeApplies to specified germline genetic sequencing procedures unless provider, state, or federal requirements indicate otherwise.

RationaleThe germline genotype does not change during a member's lifetime; reinterpretation of results does not require repeat sequencing.

Provider Actions & Billing Requirements

Note

Authorization, coding, and billing requirements

Bill services with appropriate CPT, HCPCS, and/or revenue codes and ensure claims are fully supported in the medical record and/or office notes.
Be aware that provider, state, federal, or CMS mandates may supersede this policy.

Definitions

Germline

DefinitionCells arising from the germ cells containing genetic code that may be passed down to future generations. May also be referred to as hereditary or constitutional.

Relevance to policyPolicy limits reimbursement for germline genetic sequencing to one per member lifetime because the germline genotype does not change over a lifetime.

Alternate termsHereditary; constitutional.

Genotype

DefinitionThe genotype is the individual organism's unique set of all the genes.

Policy noteGenotype is considered stable over a member's lifetime; repeat sequencing is not required solely to reassess genotype.

Use in clinical contextInforms interpretation of variants and clinical decision-making when combined with patient history.

Sequencing

DefinitionDetermining the identity of each nucleotide (one of the four chemical bases) to identify the genetic information carried in a DNA segment.

Policy implicationSequencing procedures listed in Related Coding are limited to one reimbursement per member lifetime.

PurposeUsed to generate the genetic data that may later be reinterpreted without requiring a new sequencing procedure.

Variant

DefinitionNucleotide deviation from a reference DNA sequence; clinically classified (Pathogenic; Likely pathogenic; Variant of uncertain (or unknown) significance (VUS); Likely benign; Benign).

Classification dynamicsAs evidence evolves, prior variant classifications may require modification; each laboratory assigns risk assessment per accepted schemes.

Reimbursement impactReinterpretation of previously obtained sequencing results (reclassification of variants) is not separately reimbursable; repeat sequencing is not required for reinterpretation.